USPTO serial 77321961
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
SCOTT D. WOLDOW SMITH, GAMBRELL & RUSSELL, LLP1130 CONNECTICUT AVE NW STE 1130WASHINGTON, DC 20036-3936UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics and cleaning preparations | ACTIVE | — |
| 005 | Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of disorders and diseases of the brain and the nervous system, the eyes, the respiratory tract, the immune system and the skin; analgesic, anti-rheumatic, anti-inflammatory, anti-allergic, neurological and cardiovascular medicine; pharmaceutical preparations, namely, antidiabetics; pharmaceutical preparations for the treatment of diseases of the central nervous system; Pharmaceutical Drugs Containing Chamomile for the Treatment of Disorders of the Skin, Ears, Gums and Mouth, Respiratory, Gastro-Intestinal and Urogenital Systems; pharmaceutical preparations, namely, antibiotics; pharmaceutical preparations for the treatment of infections; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of urogenital diseases and disorders; sanitary preparations for medical use; medical plasters and wound dressings | ACTIVE | — |
| 010 | Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for treating respiratory conditions; Medical inhalers for therapeutic use sold empty | ACTIVE | — |
| 035 | Management, namely, business management, business management planning, business management and advice, business management consultancy services | ACTIVE | — |
| 042 | Scientific research; Scientific research, namely, conducting clinical trials; Scientific research in the field of pharmaceuticals and clinical trials; Technological services, namely, design and testing for new product development;Technological services, namely, design and testing of new products for others; Industry analysis and research services, namely, pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development, pharmaceutical research services and testing; inspection or research of pharmaceuticals | ACTIVE | — |
| 044 | Medical services, excluding outpatient care services; healthcare, excluding outpatient care services; providing information about health care, excluding information regarding outpatient care services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 7, 2011 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 7, 2011 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 19, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Mar 18, 2011 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 15, 2011 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 15, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 18, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Sep 17, 2010 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 14, 2010 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 14, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 3, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | — |
| Apr 2, 2010 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 1, 2010 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 1, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 22, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 22, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 7, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 7, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 7, 2009 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 7, 2009 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 7, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 7, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 15, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 25, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 11, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 11, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 2, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 16, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 15, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 17, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 17, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 17, 2008 | ALIE | ASSIGNED TO LIE | — |
| Apr 15, 2008 | PAPER RECEIVED | — | |
| Feb 19, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2007 | NWAP | NEW APPLICATION ENTERED | — |